Literature DB >> 25756857

PRAGMA-CF. A Quantitative Structural Lung Disease Computed Tomography Outcome in Young Children with Cystic Fibrosis.

Tim Rosenow1, Merel C J Oudraad, Conor P Murray, Lidija Turkovic, Wieying Kuo, Marleen de Bruijne, Sarath C Ranganathan, Harm A W M Tiddens, Stephen M Stick.   

Abstract

RATIONALE: Chest computed tomography (CT) is the gold standard for demonstrating cystic fibrosis (CF) airway disease. However, there are no standardized outcome measures appropriate for children younger than 6 years.
OBJECTIVES: We developed the Perth-Rotterdam Annotated Grid Morphometric Analysis for CF (PRAGMA-CF), a quantitative measure of airway disease, and compared it with the commonly used CF-CT scoring method.
METHODS: CT scans from the Australian Respiratory Early Surveillance Team for CF (AREST CF) cohort in Western Australia were included. PRAGMA-CF was performed by annotating a grid overlaid on 10 axial slices for the presence of bronchiectasis, mucous plugging, or other airway abnormalities (inspiratory scans) and trapped air (expiratory scans). The separate proportions of total disease (%Dis), bronchiectasis (%Bx), and trapped air (%TA) were determined. Thirty scans were used for observer reliability, and 30 paired scans obtained at 1 and 3 years old were used for comparison with a validated standard and biologic plausibility.
MEASUREMENTS AND MAIN RESULTS: Intraobserver, intraclass correlation coefficients (95% confidence interval) for %Dis, %Bx, and %TA were 0.93 (0.86-0.97), 0.93 (0.85-0.96), and 0.96 (0.91-0.98), respectively. The change in %Dis (P = 0.004) and %Bx (P = 0.001) with PRAGMA-CF was related to neutrophil elastase presence at age 3, whereas only the change in bronchiectasis score was related to neutrophil elastase (P < 0.001) with CF-CT. Sample-size calculations for various effect sizes are presented.
CONCLUSIONS: PRAGMA-CF is a sensitive and reproducible outcome measure for assessing the extent of lung disease in very young children with CF.

Entities:  

Keywords:  clinical trials as topic; medical imaging; pediatrics

Mesh:

Year:  2015        PMID: 25756857     DOI: 10.1164/rccm.201501-0061OC

Source DB:  PubMed          Journal:  Am J Respir Crit Care Med        ISSN: 1073-449X            Impact factor:   21.405


  44 in total

Review 1.  Chest imaging in cystic fibrosis studies: What counts, and can be counted?

Authors:  Rhonda Szczesniak; Lidija Turkovic; Eleni-Rosalina Andrinopoulou; Harm A W M Tiddens
Journal:  J Cyst Fibros       Date:  2016-12-28       Impact factor: 5.482

2.  Cystic Fibrosis: The Dawn of a New Therapeutic Era.

Authors:  Sonya L Heltshe; Jonathan Cogen; Kathleen J Ramos; Christopher H Goss
Journal:  Am J Respir Crit Care Med       Date:  2017-04-15       Impact factor: 21.405

3.  Myeloperoxidase oxidation of methionine associates with early cystic fibrosis lung disease.

Authors:  Joshua D Chandler; Camilla Margaroli; Hamed Horati; Matthew B Kilgore; Mieke Veltman; H Ken Liu; Alexander J Taurone; Limin Peng; Lokesh Guglani; Karan Uppal; Young-Mi Go; Harm A W M Tiddens; Bob J Scholte; Rabindra Tirouvanziam; Dean P Jones; Hettie M Janssens
Journal:  Eur Respir J       Date:  2018-10-10       Impact factor: 16.671

Review 4.  Cystic Fibrosis and Pseudomonas aeruginosa: the Host-Microbe Interface.

Authors:  Sankalp Malhotra; Don Hayes; Daniel J Wozniak
Journal:  Clin Microbiol Rev       Date:  2019-05-29       Impact factor: 26.132

Review 5.  Computed tomography in cystic fibrosis lung disease: a focus on radiation exposure.

Authors:  Stella Joyce; Brian W Carey; Niamh Moore; David Mullane; Michael Moore; Mark F McEntee; Barry J Plant; Michael M Maher; Owen J O'Connor
Journal:  Pediatr Radiol       Date:  2021-03-20

6.  Airway profile of bioactive lipids predicts early progression of lung disease in cystic fibrosis.

Authors:  Hamed Horati; Hettie M Janssens; Camilla Margaroli; Mieke Veltman; Marta Stolarczyk; Matthew B Kilgore; Jeffrey Chou; Limin Peng; Harm A M W Tiddens; Joshua D Chandler; Rabindra Tirouvanziam; Bob J Scholte
Journal:  J Cyst Fibros       Date:  2020-02-10       Impact factor: 5.482

7.  Ultrashort Echo-Time Magnetic Resonance Imaging Is a Sensitive Method for the Evaluation of Early Cystic Fibrosis Lung Disease.

Authors:  David J Roach; Yannick Crémillieux; Robert J Fleck; Alan S Brody; Suraj D Serai; Rhonda D Szczesniak; Stephanie Kerlakian; John P Clancy; Jason C Woods
Journal:  Ann Am Thorac Soc       Date:  2016-11

8.  Metabolomic biomarkers predictive of early structural lung disease in cystic fibrosis.

Authors:  Charles R Esther; Lidija Turkovic; Tim Rosenow; Marianne S Muhlebach; Richard C Boucher; Sarath Ranganathan; Stephen M Stick
Journal:  Eur Respir J       Date:  2016-11-11       Impact factor: 16.671

9.  Quantitative CT characterization of pediatric lung development using routine clinical imaging.

Authors:  Jill M Stein; Laura L Walkup; Alan S Brody; Robert J Fleck; Jason C Woods
Journal:  Pediatr Radiol       Date:  2016-08-30

10.  Elastase Exocytosis by Airway Neutrophils Is Associated with Early Lung Damage in Children with Cystic Fibrosis.

Authors:  Camilla Margaroli; Luke W Garratt; Hamed Horati; A Susanne Dittrich; Timothy Rosenow; Samuel T Montgomery; Dario L Frey; Milton R Brown; Carsten Schultz; Lokesh Guglani; Anthony Kicic; Limin Peng; Bob J Scholte; Marcus A Mall; Hettie M Janssens; Stephen M Stick; Rabindra Tirouvanziam
Journal:  Am J Respir Crit Care Med       Date:  2019-04-01       Impact factor: 21.405

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.